Volta Medical Appoints Bill Hoffman as Executive Chairman

Apr 8, 2025
Volta Medical has appointed Bill Hoffman as Executive Chairman of its Board of Directors, bringing his extensive experience in guiding startups to success.
Volta Medical Appoints Bill Hoffman as Executive Chairman

Volta Medical has appointed Bill Hoffman as the Executive Chairman of its Board of Directors, announced in a press release. Hoffman, who previously served as CEO of Inari Medical, is recognized for leading the company to significant growth and its eventual acquisition by Stryker for $4.9 billion.

Volta Medical, a health technology company based in Marseille, France, focuses on developing AI solutions to assist electrophysiologists in cardiac ablation procedures. Hoffman's appointment comes as the company aims to expand global access to its AI-driven solutions, which have shown improved efficacy outcomes for atrial fibrillation patients.

In addition to Hoffman's appointment, Jerome Kalifa, MD, PhD, has been named Executive Vice Chairman while continuing his role as Chief Medical Officer. This leadership change follows the publication of the TAILORED-AF clinical trial in Nature Medicine, highlighting the effectiveness of Volta's AI-guided procedures.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.